Financings In Brief

Devicor Medical Products gets $250 million for acquisitions: Start-up seeks device acquisition to serve as a platform for growth, supported by a commitment for up to $250 million in financing from private equity firm and partner GTCR Golder Rauner. Announced March 10, the start-up is headed by CEO Thomas Daulton, former Cardinal Health general manager of Interventional Specialties and MedSystems divisions. Pleasant Prairie, Wis.-based Devicor Medical Products is seeking to buy "established interventional medical device businesses that manufacture and sell products to clinicians in settings such as hospitals, surgery centers or ambulatory clinics," the firm states. Devicor expects to complete an initial purchase in the $150 million-$400 million price range this year, supported in part with debt financing; smaller deals likely would follow, according to the company